This blog is also available in Portuguese,
» Read more about: Overcoming Immunisation Workforce Challenges Due to COVID-19 »Overcoming Immunisation Workforce Challenges Due to COVID-19
Estimated reading time: 7 minutes
This blog is also available in Portuguese,
» Read more about: Overcoming Immunisation Workforce Challenges Due to COVID-19 »This blog is also available in Portuguese,
» Read more about: National Immunization Registers – Recent Experiences in Supporting COVID-19 Vaccination and Integrating Adult and Child Vaccination Delivery »This blog is also available in Portuguese,
» Read more about: Hesitancy on the Frontline: Lessons Learned in Preparing for and Responding to Health Care Worker Hesitancy »Authors: Dr. Faisal Shuaib, Akachi Mbogu,
» Read more about: Transitioning from Donor Support: Lessons Learned from Nigeria’s Gavi Transition Plan Development »Author: Eka Paatashvili
Over this last year,
» Read more about: How to Maintain Routine Immunization During COVID-19? Experiences from Armenia, Georgia, and Uzbekistan »LNCT’s virtual workshop on the topic of financing and managing resources in decentralized contexts took place over three days in late April 2021.
» Read more about: Takeaways from LNCT’s Virtual Workshop on Financing and Managing Resources in Decentralized Contexts »This blog is also available in Portuguese,
» Read more about: Combating Vaccine Hesitancy through Storytelling: Four Key Insights on the Power of this Persuasive Approach »Authors: Ina Charkviani, Journalist and Communications Specialist,
» Read more about: Georgia COVID-19 Vaccine Communications Campaign to Address Hesitancy Issues »Authors: Jason Zhu (CHAI), Priscilla Rouyer (CHAI),
» Read more about: Market Intelligence for Action: Preparing for Gavi-Transition Part 3 – Market Intelligence Resources for Product Access and Implementation Strategies »Authors: Jason Zhu (CHAI), Priscilla Rouyer (CHAI),
» Read more about: Market Intelligence for Action: Preparing for Gavi-Transition Part 2 – Market Intelligence Resources for Vaccine Product Choice and Price »